120 related articles for article (PubMed ID: 16046313)
21. Insulin secretion, clearance and action before and after gastroplasty in severely obese subjects.
Letiexhe MR; Scheen AJ; Gérard PL; Desaive C; Lefèbvre PJ
Int J Obes Relat Metab Disord; 1994 May; 18(5):295-300. PubMed ID: 8061722
[TBL] [Abstract][Full Text] [Related]
22. Study of the effects of transoral gastroplasty on insulin sensitivity and secretion in obese subjects.
Chiellini C; Iaconelli A; Familiari P; Riccioni ME; Castagneto M; Nanni G; Costamagna G; Mingrone G
Nutr Metab Cardiovasc Dis; 2010 Mar; 20(3):202-7. PubMed ID: 19500959
[TBL] [Abstract][Full Text] [Related]
23. The metabolic clearance of insulin and the feedback inhibition of insulin secretion are altered with aging.
Fink RI; Revers RR; Kolterman OG; Olefsky JM
Diabetes; 1985 Mar; 34(3):275-80. PubMed ID: 3882495
[TBL] [Abstract][Full Text] [Related]
24. Insulin secretion and clearance during low-dose graded glucose infusion.
Byrne MM; Sturis J; Polonsky KS
Am J Physiol; 1995 Jan; 268(1 Pt 1):E21-7. PubMed ID: 7840177
[TBL] [Abstract][Full Text] [Related]
25. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients.
Miyazaki Y; DeFronzo RA
Diabetes Obes Metab; 2008 Dec; 10(12):1204-11. PubMed ID: 18476983
[TBL] [Abstract][Full Text] [Related]
26. Roles of insulin resistance and obesity in regulation of plasma insulin concentrations.
Jones CN; Abbasi F; Carantoni M; Polonsky KS; Reaven GM
Am J Physiol Endocrinol Metab; 2000 Mar; 278(3):E501-8. PubMed ID: 10710505
[TBL] [Abstract][Full Text] [Related]
27. Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome.
Cataldo NA; Abbasi F; McLaughlin TL; Basina M; Fechner PY; Giudice LC; Reaven GM
Hum Reprod; 2006 Jan; 21(1):109-20. PubMed ID: 16155076
[TBL] [Abstract][Full Text] [Related]
28. Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12.
Byrne MM; Sturis J; Menzel S; Yamagata K; Fajans SS; Dronsfield MJ; Bain SC; Hattersley AT; Velho G; Froguel P; Bell GI; Polonsky KS
Diabetes; 1996 Nov; 45(11):1503-10. PubMed ID: 8866553
[TBL] [Abstract][Full Text] [Related]
29. The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects.
Kjems LL; Holst JJ; Vølund A; Madsbad S
Diabetes; 2003 Feb; 52(2):380-6. PubMed ID: 12540611
[TBL] [Abstract][Full Text] [Related]
30. Fluid retention and vascular effects of rosiglitazone in obese, insulin-resistant, nondiabetic subjects.
Rennings AJ; Smits P; Stewart MW; Tack CJ
Diabetes Care; 2006 Mar; 29(3):581-7. PubMed ID: 16505510
[TBL] [Abstract][Full Text] [Related]
31. Comparison of glargine insulin versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylurea.
Triplitt C; Glass L; Miyazaki Y; Wajcberg E; Gastaldelli A; De Filippis E; Cersosimo E; DeFronzo RA
Diabetes Care; 2006 Nov; 29(11):2371-7. PubMed ID: 17065670
[TBL] [Abstract][Full Text] [Related]
32. Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissues.
Mandarino LJ; Gerich JE
Diabetes Care; 1984; 7 Suppl 1():89-99. PubMed ID: 6376034
[TBL] [Abstract][Full Text] [Related]
33. Insulin action and secretion in healthy, glucose tolerant first degree relatives of patients with type 2 diabetes mellitus. Influence of body weight.
Volk A; Renn W; Overkamp D; Mehnert B; Maerker E; Jacob S; Balletshofer B; Häring HU; Rett K
Exp Clin Endocrinol Diabetes; 1999; 107(2):140-7. PubMed ID: 10320055
[TBL] [Abstract][Full Text] [Related]
34. Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients.
Miyazaki Y; Mahankali A; Matsuda M; Mahankali S; Hardies J; Cusi K; Mandarino LJ; DeFronzo RA
J Clin Endocrinol Metab; 2002 Jun; 87(6):2784-91. PubMed ID: 12050251
[TBL] [Abstract][Full Text] [Related]
35. Pioglitazone-induced insulin sensitization improves vascular endothelial function in nondiabetic patients with essential hypertension.
Horio T; Suzuki M; Takamisawa I; Suzuki K; Hiuge A; Yoshimasa Y; Kawano Y
Am J Hypertens; 2005 Dec; 18(12 Pt 1):1626-30. PubMed ID: 16364837
[TBL] [Abstract][Full Text] [Related]
36. Rosiglitazone improves insulin sensitivity in nonobese subjects with impaired glucose tolerance: the role of adiponectin and C-reactive protein.
Hung YJ; Lin SH; Pei D; Kuo SW; Hsieh CH; He CT; Hsing Lee C; Fan SC; Sheu WH
Metabolism; 2006 Apr; 55(4):439-44. PubMed ID: 16546473
[TBL] [Abstract][Full Text] [Related]
37. Insulin secretion in lipodystrophic HIV-infected patients is associated with high levels of nonglucose secretagogues and insulin resistance of beta-cells.
Haugaard SB; Andersen O; Storgaard H; Dela F; Holst JJ; Iversen J; Nielsen JO; Madsbad S
Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E677-85. PubMed ID: 15149949
[TBL] [Abstract][Full Text] [Related]
38. Improvement of glucose tolerance in Zucker diabetic fatty rats by long-term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazone.
Wargent E; Stocker C; Augstein P; Heinke P; Meyer A; Hoffmann T; Subramanian A; Sennitt MV; Demuth HU; Arch JR; Cawthorne MA
Diabetes Obes Metab; 2005 Mar; 7(2):170-81. PubMed ID: 15715890
[TBL] [Abstract][Full Text] [Related]
39. Dose-dependent effects of oral and intravenous glucose on insulin secretion and clearance in normal humans.
Tillil H; Shapiro ET; Miller MA; Karrison T; Frank BH; Galloway JA; Rubenstein AH; Polonsky KS
Am J Physiol; 1988 Mar; 254(3 Pt 1):E349-57. PubMed ID: 3279811
[TBL] [Abstract][Full Text] [Related]
40. Rosiglitazone improves insulin sensitivity and lowers blood pressure in hypertensive patients.
Raji A; Seely EW; Bekins SA; Williams GH; Simonson DC
Diabetes Care; 2003 Jan; 26(1):172-8. PubMed ID: 12502676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
